MENU
Articles by #hashtag

Gedeon Richter Plc.

9 hits

Gedeon Richter Divesting in the Republic of Moldova

D&T
Jun 21, 2021

The Hungarian pharmaceutical firm Gedeon Richter Plc. announced this Monday that it signed a multi-party agreement to divest its wholesale operation to Grin-Farm S.R.L. and its retail operations to BIRIVOFARM S.R.L., both in the Republic of Moldova. Richter as a majority owner of both the wholesale and the retail operations is entitled to approximately 62% […]

Richter Expands Cooperation to Japan and Taiwan

D&T
Jun 2, 2021

Gedeon Richter Plc. has announced that it extended its existing licensing agreement with AbbVie, originally dated 2004, for the development and commercialization of its own-developed molecule, cariprazine. The initial agreement covered the territories of the USA and Canada and was extended in 2019 to include certain countries in Latin America. The present agreement further expands […]

Gedeon Richter Contraceptive Approved by the EC

D&T
May 21, 2021

The Hungarian pharmaceutical Gedeon Richter Plc. has announced that the European Commission has granted approval for the marketing authorization of the novel combined oral contraceptive containing 15 mg estetrol and 3 mg drospirenone. This decision followed a positive opinion from the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (“EMA”) […]

Pandemic Crisis Management at Gedeon Richter

D&T
May 10, 2021

As the world enters into the second year of the COVID-19 pandemic, the Hungarian pharmaceutical company Gedeon Richter Plc. continues to regularly provide a brief update of its impact on the health and wellbeing of its employees and its operations at large. According to OECD Statistics, global GDP declined by 4.2 % in 2020 due […]

Gedeon Richter Maintains Strategic Direction

D&T
Feb 26, 2021

In its 2020 report to the Budapest Stock Exchange, the Hungarian pharmaceutical company Gedeon Richter Plc. states that the company managed to service its customers on time and in full also into the last quarter of the reported year despite a sharp increase in COVID-19 case numbers in its countries of operation. Additional protective measures […]

Hungarian-Belgian Pharmaceutical Agreement

D&T
Dec 23, 2020

The Hungarian pharmaceutical company Richter and the Belgian pharma firm Mithra strengthen their partnership with the signing of a license and supply agreement for the commercialization of a novel oral contraceptive to Latin America. Gedeon Richter Plc. and Estetra S.A, the wholly owned subsidiary of Mithra Pharmaceuticals, have announced that they extended their partnership and […]

Richter Share Price Breaks Record

D&T
Aug 24, 2020

A three-year price record for the shares of the Hungarian pharmaceutical company Gedeon Richter was broken on Monday: the price rose above HUF 7,300 at the Budapest Stock Exchange. The company is one of the winners of the coronavirus epidemic, it is helped by the weakening of the Hungarian currency, and its sales are not […]

Sales Related Milestone at Gedeon Richter

D&T
Aug 3, 2020

For the first time in history, an original molecule invented by a CEE headquartered pharmaceutical company (Gedeon Richter's Vraylar), reached blockbuster status in the USA in the first half of 2020. "Thanks to the outstanding performance of our trusted partner Abbvie, Vraylar’s turnover exceeded USD 1 billion in Q2, which triggered the receipt of a […]

Reagila, developed in Hungary, Medicine of the Year

D&T
Jun 12, 2020

Richter's atypical antipsychotic, Reagila, containing the active ingredient cariprazine, was awarded the title of Drug of the Year 2019 by the Hungarian Society for Experimental and Clinical Pharmacology (HUNPHAR). Each year, the prestigious award recognizes the most advanced and effective products that have made a significant breakthrough in the cure of a disease. The award […]

© Copyright 2021 Duax Kft. –  All rights reserved.
sun